Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 5/20 | 0.43 |
| ▸ | SMPD1 | P17405 | 4/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.37 |
| ▸ | THRB | P10828 | 1/20 | 0.37 |
| ▸ | DNM1 | Q05193 | 5/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.35 |
| ▸ | GGPS1 | O95749 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL2187012 | 0.97 | FDPS (0.41) | FDPSSMPD1TSHRTHRBDNM1 | |
| SCHEMBL31244389 | 0.97 | SMPD1 (0.45) | FDPSSMPD1TSHRTHRBDNM1 | |
| SCHEMBL679279 | 0.97 | SMPD1 (0.45) | FDPSSMPD1TSHRTHRBDNM1 | |
| SCHEMBL28466918 | 0.97 | SMPD1 (0.45) | FDPSSMPD1TSHRTHRBDNM1 | |
| SCHEMBL9175206 | 0.97 | SMPD1 (0.45) | FDPSSMPD1TSHRTHRBDNM1 | |
| Water SCHEMBL10400449 | 0.95 | SMPD1 (0.44) | FDPSSMPD1TSHRTHRBDNM1 | |
| Bromide SCHEMBL11248184 | 0.95 | SMPD1 (0.44) | FDPSSMPD1TSHRTHRBDNM1 | |
| Bromide SCHEMBL28466971 | 0.95 | SMPD1 (0.44) | FDPSSMPD1TSHRTHRBDNM1 | |
| Ammonia Solution, Strong SCHEMBL28535259 | 0.95 | SMPD1 (0.44) | FDPSSMPD1TSHRTHRBDNM1 | |
| Ammonia Solution, Strong SCHEMBL28528104 | 0.95 | SMPD1 (0.44) | FDPSSMPD1TSHRTHRBDNM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190169218-A1 | AMPHIPATHIC COMPOUND HAVING NOVEL PENTA-SACCHARIDE HYDROPHILIC GROUP AND USE THEREOF | INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY ERICA CAMPUS (KR) | 2019-06-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190169218-A1 | AMPHIPATHIC COMPOUND HAVING NOVEL PENTA-SACCHARIDE HYDROPHILIC GROUP AND USE THEREOF | UGCG, APMAP, GID4 | FDPS 1595/4885SMPD1 1273/4885TSHR 2916/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.